{
    "2018-10-17": [
        [
            {
                "time": "2018-10-17",
                "original_text": "Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "TEVA",
                        "ESRX",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva",
                "features": {
                    "keywords": [
                        "Express Scripts",
                        "Amgen",
                        "Lilly",
                        "migraine drugs",
                        "excludes Teva"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva",
                "features": {
                    "keywords": [
                        "Express Scripts",
                        "Amgen",
                        "Lilly",
                        "migraine drugs",
                        "excludes Teva"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Stocks - Netflix Soars in Pre-market; IBM, Tilray, Canopy Growth Sink; Tesla Rises",
                "features": {
                    "keywords": [
                        "Netflix",
                        "Pre-market",
                        "IBM",
                        "Tilray",
                        "Canopy Growth",
                        "Tesla"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "cannabis",
                        "automotive"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off",
                "features": {
                    "keywords": [
                        "Teva Pharmaceutical",
                        "Sell-Off",
                        "Negative"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "5 Blue Chip Drug Stocks Poised for Long-Term Gains",
                "features": {
                    "keywords": [
                        "Blue Chip",
                        "Drug Stocks",
                        "Long-Term Gains"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}